Edwards Lifesciences Corporation (EW) Ownership
EW ownership summary
as of October 18, 2026- Institutions
- 95.7% of shares outstanding
- Insiders
- 0.19% of shares outstanding
- Shares outstanding
- 576.4M
- Float
- 574.5M shares available to trade
- Short interest
- 1.88% 9.5M shares short
- Days to cover
- 2.78 short interest up 5.7% vs prior month
- Institutions 95.67%
- Insiders 0.19%
- Other investors 4.14%
EW top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 10.20% | 58.8M | $5.09B | +6.2M (+11.8%) | June 30, 2026 |
| 2 | Vanguard Capital Management, LLC | 6.53% | 37.6M | $3.26B | −111,840 (−0.3%) | June 30, 2026 |
| 3 | Vanguard Portfolio Management, LLC | 4.58% | 26.4M | $2.29B | +4,384 (+0.0%) | June 30, 2026 |
| 4 | State Street Corp | 4.57% | 26.3M | $2.28B | +25,541 (+0.1%) | June 30, 2026 |
| 5 | JPMorgan Chase & Co | 3.95% | 22.8M | $1.97B | +1.0M (+4.8%) | June 30, 2026 |
| 6 | Wellington Management Company LLP | 2.92% | 16.8M | $1.46B | −5.2M (−23.5%) | June 30, 2026 |
| 7 | Geode Capital Management, LLC | 2.68% | 15.4M | $1.34B | +2.3M (+17.5%) | June 30, 2026 |
| 8 | Bank of New York Mellon Corp | 2.44% | 14.1M | $1.22B | −2.7M (−15.9%) | June 30, 2026 |
| 9 | DZ BANK AG Deutsche Zentral-Genossenschaftsbank Frankfurt am Main | 2.26% | 13.0M | $1.13B | +191,063 (+1.5%) | June 30, 2026 |
| 10 | Ninety One UK Limited | 2.14% | 12.3M | $1.07B | −58,641 (−0.5%) | June 30, 2026 |
| 11 | Aristotle Capital Management LLC | 1.50% | 8.7M | $750.5M | +8.7M (0.0%) | June 30, 2026 |
| 12 | AllianceBernstein L.P. | 1.50% | 8.7M | $750.0M | +5.2M (+149.8%) | June 30, 2026 |
| 13 | FMR Inc | 1.46% | 8.4M | $730.6M | −6.1M (−41.8%) | June 30, 2026 |
| 14 | NORGES BANK | 1.45% | 8.4M | $725.2M | −1.1M (−11.2%) | June 30, 2026 |
| 15 | Brown Advisory Holdings Inc | 1.28% | 7.4M | $637.9M | +336,475 (+4.8%) | June 30, 2026 |
| 16 | Bank of America Corp | 1.16% | 6.7M | $579.6M | +2.8M (+72.3%) | June 30, 2026 |
| 17 | Artisan Partners Limited Partnership | 1.15% | 6.6M | $573.8M | +1.4M (+27.4%) | June 30, 2026 |
| 18 | Morgan Stanley - Brokerage Accounts | 1.10% | 6.3M | $549.0M | −721,508 (−10.2%) | June 30, 2026 |
| 19 | Deutsche Bank AG | 0.99% | 5.7M | $494.5M | −344,739 (−5.7%) | June 30, 2026 |
| 20 | Arrowstreet Capital Limited Partnership | 0.98% | 5.7M | $491.7M | +3.8M (+200.3%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 12 holders added 32.0M shares and 8 cut 16.2M.
EW top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 3.17% | 18.3M | $1.58B | −36,912 (−0.2%) | August 31, 2026 |
| 2 | Vanguard 500 Index Investor | 2.63% | 15.1M | $1.31B | −158,256 (−1.0%) | September 30, 2026 |
| 3 | Vanguard MStar Mid Cap Index Instl | 2.14% | 12.3M | $1.07B | −112,149 (−0.9%) | September 30, 2026 |
| 4 | Vanguard Health Care Inv | 1.85% | 10.7M | $925.5M | −4.1M (−27.9%) | June 30, 2026 |
| 5 | iShares Core S&P 500 ETF | 1.33% | 7.7M | $665.4M | −12,358 (−0.2%) | September 30, 2026 |
| 6 | Fidelity 500 Index | 1.30% | 7.5M | $647.3M | +28,711 (+0.4%) | August 31, 2026 |
| 7 | State Street® SPDR® S&P 500® ETF | 1.23% | 7.1M | $613.6M | — | September 30, 2026 |
| 8 | Vanguard MStar Value Index Investor | 0.95% | 5.5M | $475.5M | −9,896 (−0.2%) | September 30, 2026 |
| 9 | Vanguard MStar Mid Cap Growth ETF | 0.79% | 4.5M | $391.9M | +101,773 (+2.3%) | September 30, 2026 |
| 10 | State Street®HlthCrSelSectSPDR®ETF | 0.71% | 4.1M | $354.0M | +12,720 (+0.3%) | September 30, 2026 |
| 11 | JPMorgan US Equity L | 0.63% | 3.6M | $313.4M | −221,822 (−5.8%) | August 31, 2026 |
| 12 | Vanguard Windsor II Inv | 0.54% | 3.1M | $270.3M | +3.1M (0.0%) | June 30, 2026 |
| 13 | BGF World Healthscience A2 | 0.54% | 3.1M | $267.1M | — | June 30, 2026 |
| 14 | Vanguard Institutional Index I | 0.53% | 3.0M | $264.0M | −30,593 (−1.0%) | September 30, 2026 |
| 15 | Ninety One GSF Glb Frchs I Acc USD | 0.51% | 2.9M | $253.8M | — | June 30, 2026 |
| 16 | UniGlobal | 0.48% | 2.8M | $240.9M | −237 (−0.0%) | August 31, 2026 |
| 17 | UniGlobal Vorsorge | 0.42% | 2.4M | $208.7M | −999,662 (−29.3%) | August 31, 2026 |
| 18 | iShares Russell Mid-Cap ETF | 0.41% | 2.4M | $203.9M | +4,332 (+0.2%) | September 30, 2026 |
| 19 | Invesco S&P 500® Equal Weight ETF | 0.39% | 2.3M | $196.8M | −4,750 (−0.2%) | September 30, 2026 |
| 20 | Fidelity Mid Cap Index | 0.38% | 2.2M | $188.3M | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
EW insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-09 | Scott B Ullem | Sell | $80.04 | 13,000 | $1.0M |
| 2026-04-06 | Daniel J Lippis | Sell | $80.98 | 1,019 | $82,519 |
| 2026-04-02 | Donald E Bobo Jr | Sell | $80.16 | 22,680 | $1.8M |
| 2026-03-30 | Ro Khanna | Sell | $79.52 | — | — |
| 2026-03-23 | Ro Khanna | Buy | $81.95 | — | — |
| 2026-03-11 | Daniel J Lippis | Sell | $85.38 | 1,019 | $87,002 |
| 2026-03-11 | Scott B Ullem | Sell | $84.92 | 13,000 | $1.1M |
| 2026-03-02 | Donald E Bobo Jr | Sell | $85.93 | 11,340 | $974,446 |
| 2026-02-25 | Donald E Bobo Jr | Sell | $83.84 | 24,000 | $2.0M |
| 2026-02-05 | Ro Khanna | Sell | $78.06 | — | — |
| 2026-01-09 | Daniel J Lippis | Sell | $85.70 | 1,019 | $87,328 |
| 2026-01-06 | Donald E Bobo Jr | Sell | $85.66 | 11,340 | $971,384 |
| 2025-12-12 | Daniel J Lippis | Sell | $84.03 | 1,019 | $85,627 |
| 2025-12-12 | Donald E Bobo Jr | Sell | $83.76 | 11,386 | $953,691 |
| 2025-12-10 | Donald E Bobo Jr | Sell | $83.83 | 11,340 | $950,632 |
| 2025-12-09 | Scott B Ullem | Sell | $84.47 | 7,700 | $650,419 |
| 2025-11-19 | Josh Gottheimer | Sell | $85.85 | — | — |
| 2025-11-10 | Daniel J Lippis | Sell | $82.55 | 1,020 | $84,201 |
| 2025-11-10 | Scott B Ullem | Sell | $83.08 | 13,000 | $1.1M |
| 2025-10-07 | Ro Khanna | Sell | $76.70 | — | — |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
EW shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns EW
Institutional investors own 95.7% of Edwards Lifesciences's shares and insiders 0.19%. The largest holder is BlackRock Inc with 10.20% of the shares (58.8M), as of June 30, 2026. Among the top 20 institutions, 12 added shares and 8 reduced their stake in the latest filings. Short interest is 1.88% of the float, or 2.78 days of average trading volume. The share count fell 11.6% since 2014.
Related: EW analyst forecast, EW key metrics. See the EW stock overview for the latest quote and news.
EW ownership FAQ
Who owns the most Edwards Lifesciences stock?
The largest shareholders of Edwards Lifesciences are BlackRock Inc (10.20%), Vanguard Capital Management, LLC (6.53%), Vanguard Portfolio Management, LLC (4.58%), State Street Corp (4.57%), JPMorgan Chase & Co (3.95%).
What percentage of Edwards Lifesciences is owned by institutions?
Institutions hold 95.7% of Edwards Lifesciences's shares outstanding; insiders hold 0.19%.
Which funds own Edwards Lifesciences?
The largest fund holders of Edwards Lifesciences are Vanguard MStar Total Stk Mkt Idx Invest (3.17%), Vanguard 500 Index Investor (2.63%), Vanguard MStar Mid Cap Index Instl (2.14%), Vanguard Health Care Inv (1.85%), iShares Core S&P 500 ETF (1.33%).
What is Edwards Lifesciences's short interest?
9.5M shares of Edwards Lifesciences were sold short, 1.88% of the float; at the average daily volume it would take 2.78 days to cover.
Are insiders buying or selling Edwards Lifesciences?
Of the latest 20 reported insider transactions in Edwards Lifesciences (since October 7, 2025), 1 were purchases and 19 were sales.
How many shares of Edwards Lifesciences are outstanding?
Edwards Lifesciences has 576.4M shares outstanding, of which 574.5M are in the public float.